| abstract |
The present invention relates to a composite preparation for the prevention or treatment of cardiovascular diseases, comprising aspirin coated with a separator containing a hydrophobic additive, and HMG-CoA reductase inhibitor, wherein the combination preparation is HMG by salicylic acid released from aspirin It prevents the deterioration of -CoA stability and excellent storage stability, it can be usefully used for the treatment of hypertension and hypercholesterolemia. |